{
  "claim_id": "claim_002",
  "claim": "Cell- and egg-based flu vaccines have the potential to develop mutations during production, which may reduce their effectiveness.",
  "document": {
    "pdf_name": "Zimmerman_et_al.__2023_"
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 1
  },
  "extracted_evidence": [
    {
      "id": "comp_1",
      "quote": "because it is not subject to mutations to the A (H3 N2) glycosylation binding site that reduce the effectiveness of egg based vaccines.",
      "relevance_explanation": "This quote directly states that egg-based vaccines are subject to mutations at a specific site, which can reduce their effectiveness, supporting the claim about mutation risk in production.",
      "source": "completeness_check",
      "metadata": {
        "extraction_round": 2,
        "targeted_aspect": "general"
      }
    }
  ]
}